Skip to main content
logo
Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
37.72
-1.34 (-3.43%)
At close: Mar 3, 2026, 4:00 PM EST
38.20
+0.48 (1.27%)
After-hours: Mar 3, 2026, 7:18 PM EST

Soleno Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
20.89-175.85-38.99-24.07-30.91
Depreciation & Amortization
2.021.991.961.961.96
Other Amortization
0.04----
Loss (Gain) From Sale of Investments
-3.52-4.9---
Stock-Based Compensation
45.8599.965.952.533.28
Other Operating Activities
6.163.693.22-0.45-0.95
Change in Accounts Receivable
-28.21----
Change in Inventory
-14.03----
Change in Accounts Payable
3.615.671.37-1.48-0.24
Change in Other Net Operating Assets
13.990.351.560.72-0.91
Operating Cash Flow
46.8-69.1-24.94-20.78-27.77
Capital Expenditures
-0.07-0.22--0.01-0.02
Investment in Securities
-201.71-225.46---
Investing Cash Flow
-201.78-225.68--0.01-0.02
Long-Term Debt Issued
-49.89---
Long-Term Debt Repaid
-----0.01
Total Debt Repaid
-----0.01
Net Debt Issued (Repaid)
-49.89---0.01
Issuance of Common Stock
238.11163.14180.0214.11-
Repurchase of Common Stock
-100.89---0.02-0.12
Other Financing Activities
-0.06----
Financing Cash Flow
137.16213.03180.0214.09-0.13
Net Cash Flow
-17.82-81.75155.08-6.7-27.92
Free Cash Flow
46.73-69.31-24.94-20.79-27.79
Free Cash Flow Margin
24.54%----
Free Cash Flow Per Share
0.89-1.73-1.51-2.48-5.23
Cash Interest Paid
4.530.21---
Levered Free Cash Flow
48.27-7.47-12.82-11.71-15.79
Unlevered Free Cash Flow
51.66-7.33-12.82-11.71-15.79
Change in Working Capital
-24.636.022.93-0.76-1.15
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q